Dec 2023 An Overview of Testing Capabilities to Identify Use of Marijuana (THC) and Other Natural Cannabinoids
Following the passing of the 2018 Agriculture Improvement Act (a.k.a. Farm Bill), the cannabis industry has seen widespread growth in...
In Practice: Clinical Insights
Nov 2023 Synthetic Stimulants
Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of scheduled or illicit...
Oct 2023 Nitazene Analogs
Nitazene analogs are a subclass of designer opioids that are structurally different from opioids but attach to the same mu-opioid...
Sep 2023 Designer Benzodiazepines
Designer benzodiazepines (DZBDs) represent a major public health issue and their prevalence has increased substantially over the last decade.1 Slight...
Aug 2023 What Did My Patient Actually Take? An Overview of Alcohol Results
According to the National Survey on Drug Use and Health conducted in 2015, 86.4% of people over the age of...
Aug 2023 Synthetic Cannabinoids
Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of prescription or illicit...
